The scholars considered that ITIH4 was a novel biomarker in inflammatory responses for AIS due to its close relationship with S-100 β-β, neuron specific enolase (NSE), interleukin-2 (IL-2), and interleukin-10 (IL-10) expression [54]. This evidence concerns the gene IL2 and androgen insensitivity syndrome.